MAIORANA, Antonino
 Distribuzione geografica
Continente #
NA - Nord America 40.016
EU - Europa 21.897
AS - Asia 14.867
SA - Sud America 2.361
Continente sconosciuto - Info sul continente non disponibili 599
AF - Africa 418
OC - Oceania 62
Totale 80.220
Nazione #
US - Stati Uniti d'America 38.918
IT - Italia 9.670
GB - Regno Unito 4.566
SG - Singapore 4.506
CN - Cina 3.757
BR - Brasile 1.784
HK - Hong Kong 1.655
VN - Vietnam 1.529
SE - Svezia 1.475
DE - Germania 1.432
RU - Federazione Russa 781
FI - Finlandia 744
UA - Ucraina 732
FR - Francia 714
BD - Bangladesh 692
TR - Turchia 612
CA - Canada 571
IN - India 454
IE - Irlanda 402
KR - Corea 353
NL - Olanda 294
BG - Bulgaria 282
ID - Indonesia 234
MX - Messico 185
AR - Argentina 166
JP - Giappone 155
PL - Polonia 132
IQ - Iraq 123
PK - Pakistan 101
CH - Svizzera 98
ZA - Sudafrica 95
AE - Emirati Arabi Uniti 92
CO - Colombia 91
MY - Malesia 91
BE - Belgio 83
ES - Italia 83
EC - Ecuador 79
CR - Costa Rica 74
IL - Israele 69
EG - Egitto 68
CL - Cile 67
PH - Filippine 61
AU - Australia 57
IR - Iran 57
LT - Lituania 56
VE - Venezuela 53
AT - Austria 52
SA - Arabia Saudita 43
UZ - Uzbekistan 40
PY - Paraguay 39
MA - Marocco 38
CZ - Repubblica Ceca 35
RO - Romania 35
PE - Perù 34
TN - Tunisia 34
AL - Albania 33
JM - Giamaica 33
NG - Nigeria 33
DZ - Algeria 32
KE - Kenya 31
PR - Porto Rico 31
HN - Honduras 30
SC - Seychelles 29
SV - El Salvador 29
JO - Giordania 27
PT - Portogallo 27
RS - Serbia 27
AZ - Azerbaigian 24
TH - Thailandia 24
TW - Taiwan 24
GR - Grecia 23
NI - Nicaragua 23
BO - Bolivia 22
GT - Guatemala 22
UY - Uruguay 22
EU - Europa 19
NP - Nepal 19
KZ - Kazakistan 18
TT - Trinidad e Tobago 18
CW - ???statistics.table.value.countryCode.CW??? 17
DK - Danimarca 17
GP - Guadalupe 16
OM - Oman 16
DO - Repubblica Dominicana 15
BB - Barbados 14
BY - Bielorussia 14
ET - Etiopia 14
HR - Croazia 14
BH - Bahrain 12
PA - Panama 12
HU - Ungheria 11
LB - Libano 11
BZ - Belize 10
SK - Slovacchia (Repubblica Slovacca) 10
GE - Georgia 9
PS - Palestinian Territory 9
MD - Moldavia 8
NO - Norvegia 8
KG - Kirghizistan 7
LK - Sri Lanka 7
Totale 79.514
Città #
Ashburn 4.952
Southend 3.141
Santa Clara 3.071
Fairfield 2.981
Singapore 2.930
Chandler 1.801
San Jose 1.626
Woodbridge 1.607
Hong Kong 1.606
Houston 1.415
Jacksonville 1.267
Seattle 1.166
Council Bluffs 1.149
Dearborn 1.086
Wilmington 1.047
Ann Arbor 1.025
Cambridge 1.008
Hefei 995
Nyköping 878
Milan 838
Chicago 789
Los Angeles 762
Beijing 743
London 681
New York 649
Rome 603
Helsinki 486
Ho Chi Minh City 467
Modena 452
Dublin 386
The Dalles 383
Hanoi 339
Salt Lake City 336
Izmir 334
San Diego 330
Seoul 318
Princeton 302
Munich 299
Sofia 266
Dallas 242
São Paulo 242
Buffalo 237
Lauterbourg 221
Eugene 210
Bologna 208
Naples 192
Moscow 191
Shanghai 186
Columbus 160
Florence 159
Tampa 158
Jakarta 144
Toronto 141
Elk Grove Village 140
Boardman 137
Phoenix 130
Frankfurt am Main 123
Orem 101
Redwood City 100
Tokyo 97
Turin 97
Palermo 95
Bari 84
Atlanta 83
Bremen 83
Des Moines 82
Fremont 81
Brooklyn 79
Da Nang 79
Warsaw 78
Sterling 77
Lancaster 74
Haiphong 70
Ottawa 69
Denver 68
Mumbai 65
Padova 63
Turku 62
Mexico City 59
Brussels 58
Chennai 58
Genoa 58
New Delhi 58
Cagliari 56
Montreal 55
Catania 54
Grafing 54
Philadelphia 54
Miami 53
Guangzhou 52
Norwalk 52
Falls Church 50
Boston 49
Dong Ket 49
San José 49
Parma 48
Rio de Janeiro 48
Verona 47
Stockholm 46
Baghdad 44
Totale 50.573
Nome #
Angiomixoma aggressivo della pelvi e del perineo. Presentazione di un caso clinico e revisione della letteratura 6.244
VALORE PROGNOSTICO E PREDITTIVO DI p53 NEL CARCINOMA MAMMARIO TRATTATO CON CHEMIOTERAPIA NEOADIUVANTE 1.191
Type 3 hypersensitivity in COVID-19 vasculitis 999
Spiradenoma eccrino al dorso della mano: presentazione di un caso 717
Post-mortem diagnosis of encephalitis in a 75-year-old man associated with human herpesvirus-6 variant A 613
Ex-vivo Fluorescence Confocal Microscopy: The First Application For Real-Time Pathologic Examination of Prostatic Tissue 541
COVID-19-associated vasculitis and thrombotic complications: from pathological findings to multidisciplinary discussion 540
Impressive response to dose-dense chemotherapy in a patient with NUT midline carcinoma 493
Incidence, clinical characteristics and survival of malignant lymphomas: a population-based study from a cancer registry in northern Italy. 489
Liver Angiopoietin-2 is a key predictor of de novo or recurrent hepatocellular cancer after HCV direct-acting antivirals 472
Atypical Spitzoid melanocytic tumors:A morphological, mutational, and FISH analysis 469
Microenvironment inflammatory infiltrate drives growth speed and outcome of hepatocellular carcinoma: a prospective clinical study 460
Comparison of HER-2 and hormone receptor expression in primary breast cancers and asynchronous paired metastases: impact on patient management 449
Soluble TRAIL Armed Human MSC As Gene Therapy For Pancreatic Cancer 449
Assessment of freezing effects and diagnostic potential of BioBank healthy and neoplastic breast tissues through HR-MAS NMR spectroscopy 447
A case of primary cardiac angiosarcoma: extensive right atrial wall reconstruction with autologous pericardium. 445
Alterations of 9p21 analysed by FISH and MLPA distinguish atypical spitzoid melanocytic tumours from conventional Spitz's nevi but do not predict their biological behaviour 437
Cutaneous metastases as the first manifestation of pleural malignant mesothelioma. 436
Two fatal cases of acute liver failure due to HSV-1 infection in COVID-19 patients following immunomodulatory therapies. 429
Granular cell tumor of the appendix: a new case and review of the literature 427
The miR-196b miRNA inhibits the GATA6 intestinal transcription factor and is upregulated in colon cancer patients 427
Cytomegalovirus infection of the upper gastrointestinal tract: a clinical and pathological study of 30 cases. 422
Bone marrow failure associated with human herpesvirus 8 infection after transplantation 420
Superficial papillary urothelial carcinomas in young and elderly patients: a comparative study. 420
Experimental varicocele in the rat: early evaluation of the nitric oxide levels and histological alterations in the testicular tissue. 419
Differential molecular pathways expression in HER2 positive early breast cancer according to hormone receptor status. 419
Well-differentiated papillary mesothelioma of the epididymis in a man with recurrent haematospermia. 417
Phase II, randomized trial of preoperative epirubicin-paclitaxel +/- gefitinib with biomarker evaluation in operable breast cancer. 414
INI1 immunohistochemical expression in glioblastoma: correlation with MGMT gene promoter methylation status and patient survival 414
MODULAZIONE DELL’ESPRESSIONE DI BIOMARCATORI E PROGNOSI IN PAZIENTI AFFETTE DA CARCINOMA MAMMARIO OPERABILE SOTTOPOSTE A CHEMIOTERAPIA PREOPERATORIA 411
A prognostic model based on nodal status and Ki-67 predicts the risk of recurrence and death in breast cancer patients with residual disease after preoperative chemotherapy 409
SOLUBLE TRAIL-ARMED HUMAN AD-MSC AS NOVEL CELL THERAPY APPROACH FOR PANCREATIC DUCTAL ADENOCARCINOMA 406
Sentinel lymph node biopsy in clear cell sarcoma. 397
Localized pleural metastatic adenosarcoma of the uterine cervix mimicking a malignant solitary fibrous tumour: CD10 has no value in differential diagnosis 393
Dystroglycan expression is reduced during prostate tumorigenesis and is regulated by androgens in prostate cancer cells 391
Malacoplachia del testicolo. Descrizione di un caso. 386
Molecular Profile, as detected with Mass-Array Spectrometry (Sequenom platform), in primary and metastatic breast carcinoma treated with Exemestane + Everolimus 386
"Is this case of a very rare disease work-related?" a review of reported cases of pacinian neuroma 384
Genomic alterations at the basis of treatment resistance in metastatic breast cancer: Clinical applications 384
Prognostic significance of MGMT gene promoter methylation in differently treated metastatic melanomas 384
Mutational Profile of Metastatic Breast Cancer Tissue in Patients Treated with Exemestane Plus Everolimus 383
Association of tumor-infiltrating lymphocytes with distant disease-free survival in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancer. 382
Acquired immunodeficiency similar to Gulf War illness in a dead former serviceman 381
Placental transmogrification of the lung: Clinicopathologic, immunohistochemical and molecular study of two cases, with particular emphasis on the interstitial clear cells 381
Human herpesvirus-8 DNA sequences in Human Immunodeficiency Virus-negative angioimmunoblastic lymphadenopathy and benign lymphadenopathy with giant germinal center hyperplasia and increased vascularity 379
Epidermal growth factor receptor gene copy number, K-ras mutation and pathological response to preoperative cetuximab, 5-FU and radiation therapy in locally advanced rectal cancer.. 377
Ex vivo fluorescence confocal microscopy: prostatic and periprostatic tissues atlas and evaluation of the learning curve 369
Prognostic relevance of serum beta2 microglobulin in patients with follicular lymphoma treated with anthracycline-containing regimens. A GISL study. 367
Predictive and prognostic role of p53 according to tumor phenotype in breast cancer patients treated with preoperative chemotherapy: a single-institution analysis 367
Survivin modulates squamous cell carcinoma-derived stem-like cell proliferation, viability and tumor formation in vivo 366
Correlating tumor-infiltrating lymphocytes and lung cancer stem cells: a cross-sectional study. 366
Human cytomegalovirus infection of the gastrointestinal tract in apparently immunocompetent patients 365
Analysis of KRAS, NRAS, PIK3CA, and BRAF mutational profile in poorly differentiated clusters of KRAS-mutated colon cancer 362
Surgical margins in head and neck squamous cell carcinoma: what is 'close'? 362
Real-time assessment of surgical margins during radical prostatectomy: a novel approach that uses fluorescence confocal microscopy for the evaluation of peri-prostatic soft tissue 358
Role of chemotherapy and the receptor tyrosine kinases KIT, PDGFR alpha, PDGFR beta, and met in large-cell neuroendocrine carcinoma of the lung 356
Psoriasis vs allergic contact dermatitis in palms and soles: A quantitative histologic and immunohistochemical study 354
Cancer stem-neuroendocrine cells in an atypical carcinoid case report. 353
ALDH Expression in Angiosarcoma of the Lung: A Potential Marker of Aggressiveness? 353
Clinical and molecular predictors of long-term response in HER2 positive metastatic breast cancer patients. 352
Overall survival in patients with lung adenocarcinoma harboring "niche" mutations: an observational study 348
BRAFp.V600E, p.V600K, and p.V600R Mutations in Malignant Melanoma: Do They Also Differ in Immunohistochemical Assessment and Clinical Features? 347
Can prostatitis to be a confounding parameter in prostatic proteomic profile designation? 343
Prediction of distant recurrence in resected stage I and II lung adenocarcinoma 343
Role of evaluating tumor‑infiltrating lymphocytes, programmed death‑1 ligand 1 and mismatch repair proteins expression in malignant mesothelioma 341
BRAF V600E mutation in washing liquid of thyroid fine-needle aspiration: a surprising tool in cytological benign nodules. 338
NF1 truncating mutations associated to aggressive clinical phenotype with elephantiasis neuromatosa and solid malignancies 337
Modulation of Mutational Landscape in HER2-Positive Breast Cancer after Neoadjuvant Chemotherapy 337
Isolation and Characterization of Squamous Cell Carcinoma-Derived Stem-like Cells: Role in Tumor Formation 336
Molecular profile in primary and metastatic breast cancer treated with Exemestane and Everolimus. 331
Dismal outcome of t-cell lymphoma patients failing first-line treatment: results of a population-based study from the Modena Cancer Registry 330
A new case of juxtaglomerular cell tumor in a patient with bilateral adrenalectomy because of MEN2A 329
Differential gene expression patterns in HER2 positive metastatic breast cancer patients according to hormone receptor status 329
Cancer Stem-Like Cells in a Case of an Inflammatory Myofibroblastic Tumor of the Lung. 329
Chronic and recurrent benign lymphadenopathy without constitutional symptoms associated with human herpesvirus-6B reactivation 326
Decreasing incidence of gastric MALT lymphomas in the era of anti-Helicobacter pilori interventions: results from a population-based study on extranodal marginal zone lymphomas 325
ASSESSMENT OF FREEZING EFFECTS AND DIAGNOSTIC POTENTIAL OF BIOBANK HEALTHY AND NEOPLASTIC BREAST TISSUES THROUGH HR-MAS NMR SPECTROSCOPY 324
A randomized controlled trial comparing three single-incision minislings for stress urinary incontinence 321
Adenolipoma della trachea. Descrizione di un caso trattato mediante resezione-anastomosi tracheale. 320
Changes in survivin subcellular localization correlates with different stages of differentiation in normal and cancerous skin 319
Prediction of Distant Recurrence-Free Survival in Resectable Lung Adenocarcinoma. 319
Identification of families with hereditary breast and ovarian cancer for clinical and mammographic surveillance: the Modena Study Group proposal 317
Durable remission in a patient with leptomeningeal relapse of a MYC/BCL6-positive double-hit DLBCL treated with lenalidomide monotherapy 316
CLINICAL AND PATHOLOGICAL FEATURES OF BREAST CANCER IN PATIENTS WITH SYSTEMIC SCLEROSIS: PRELIMINARY DATA FROM THE SCLERO-BREAST STUDY 316
Double-blind, placebo-controlled, multicenter, randomized, phase IIb neoadjuvant study of letrozole-lapatinib in postmenopausal hormone receptor-positive, human epidermal growth factor receptor 2-negative, operable breast cancer 314
An unusual case of signet ring cell adenocarcinoma of the prostate 314
Expression of nuclear survivin in normal skin and squamous cell carcinoma: a possible role in tumor invasion 313
Pre-miR146a expression in follicular carcinomas of the thyroid 311
Isolation and Identification of Cancer Stem-Like Cells in Adenocarcinoma and Squamous Cell Carcinoma of the Lung: A Pilot Study 309
Expression and clinicopathological role of miR146a in thyroid follicular carcinoma. 307
CD44+/EPCAM+ cells detect a subpopulation of ALDHhigh cells in human non-small cell lung cancer: A chance for targeting cancer stem cells? 305
Osteoid Osteoma of the Atlas in a Boy: Clinical and Imaging Features-A Case Report and Review of the Literature 304
A proof of evidence supporting abnormal immunothrombosis in severe COVID-19: naked megakaryocyte nuclei increase in the bone marrow and lungs of critically ill patients 304
Does HPV play a role in the etiopathogenesis of ameloblastoma? An immunohistochemical, in situ hybridization and polymerase chain reaction study of 18 cases using laser capture microdissection 303
Pre-miR146a expression profiling of follicular thyroid carcinoma 300
Gastrointestinal stromal tumor and other primary metachronous and synchronous neoplasms as a suspicious criterion for syndromic setting 297
Prospective biomarker analysis of the randomized CHER-LOB study evaluating the dual anti-HER2 treatment with trastuzumab and lapatinib plus chemotherapy as neoadjuvant therapy for HER2-positive breast cancer 295
Expression of ALDH and SOX-2 in Pulmonary Sclerosing Pnemocytoma (PSP) of the Lung: Is There a Meaning Behind? 295
p16 immunohistochemistry of multiple primary melanomas as screening to identify Familial Melanoma Syndrome 295
Medullary carcinoma of the thyroid gland with sustentacular cell-like cells in a patient with multiple endocrine neoplasia, type IIA. Report of a case with ultrastructural and immunohistochemical studies. 294
Totale 44.964
Categoria #
all - tutte 286.277
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 286.277


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224.155 0 0 0 0 223 405 289 333 645 541 1.019 700
2022/20236.327 711 638 454 564 647 758 227 519 997 135 322 355
2023/20244.857 198 275 241 450 951 515 435 492 141 281 381 497
2024/202511.736 471 206 278 866 2.169 1.764 941 737 1.296 643 989 1.376
2025/202622.125 1.306 794 1.721 2.999 4.368 1.385 2.221 1.037 1.990 1.729 1.521 1.054
2026/20276.712 671 1.258 1.615 2.940 228 0 0 0 0 0 0 0
Totale 80.220